SEC Form D private-offering filing

Pelage Pharmaceuticals, Inc.

Name: Pelage Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Los Angeles, CA
Published: 2025-11-24

A new SEC Form D private-offering notice from Los Angeles, CA, a $119,999,987 filer-stated offering target in Biotech. The source filing is one click away.

Pelage Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Develops PP405, a topical small molecule therapy designed to reactivate dormant hair follicle stem cells to treat hair loss.

Filed 2025-11-24Filed to raise $119,999,987First money in 2025-09-18Raised so far $119,999,987HQ (as filed) Los Angeles, CASector Biotech ✓Stage (inferred) LateCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified pelagepharma.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.